vs

Side-by-side financial comparison of NEKTAR THERAPEUTICS (NKTR) and WESTWOOD HOLDINGS GROUP INC (WHG). Click either name above to swap in a different company.

WESTWOOD HOLDINGS GROUP INC is the larger business by last-quarter revenue ($25.0M vs $21.8M, roughly 1.1× NEKTAR THERAPEUTICS). WESTWOOD HOLDINGS GROUP INC runs the higher net margin — 3.1% vs -165.4%, a 168.6% gap on every dollar of revenue. On growth, WESTWOOD HOLDINGS GROUP INC posted the faster year-over-year revenue change (7.4% vs -25.3%). Over the past eight quarters, WESTWOOD HOLDINGS GROUP INC's revenue compounded faster (4.9% CAGR vs 0.4%).

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

Westwood Studios, Inc. was an American video game developer based in Las Vegas, Nevada. It was founded by Brett Sperry and Louis Castle in 1985 as Brelous Software, but got changed after 2 months into Westwood Associates and was renamed to Westwood Studios when Virgin Games bought the company in 1992. The company was bought by Electronic Arts alongside Virgin Interactive's North American operations in 1998. In January 2003, it was announced that Westwood, alongside Westwood Pacific, would be ...

NKTR vs WHG — Head-to-Head

Bigger by revenue
WHG
WHG
1.1× larger
WHG
$25.0M
$21.8M
NKTR
Growing faster (revenue YoY)
WHG
WHG
+32.6% gap
WHG
7.4%
-25.3%
NKTR
Higher net margin
WHG
WHG
168.6% more per $
WHG
3.1%
-165.4%
NKTR
Faster 2-yr revenue CAGR
WHG
WHG
Annualised
WHG
4.9%
0.4%
NKTR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NKTR
NKTR
WHG
WHG
Revenue
$21.8M
$25.0M
Net Profit
$-36.1M
$782.0K
Gross Margin
Operating Margin
-126.9%
Net Margin
-165.4%
3.1%
Revenue YoY
-25.3%
7.4%
Net Profit YoY
-596.9%
EPS (diluted)
$-4.67
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NKTR
NKTR
WHG
WHG
Q1 26
$25.0M
Q4 25
$21.8M
$27.1M
Q3 25
$11.8M
$24.3M
Q2 25
$11.2M
$23.1M
Q1 25
$10.5M
$23.3M
Q4 24
$29.2M
$46.5M
Q3 24
$24.1M
$23.7M
Q2 24
$23.5M
$22.7M
Net Profit
NKTR
NKTR
WHG
WHG
Q1 26
$782.0K
Q4 25
$-36.1M
$1.8M
Q3 25
$-35.5M
$3.7M
Q2 25
$-41.6M
$1.0M
Q1 25
$-50.9M
$478.0K
Q4 24
$7.3M
$3.7M
Q3 24
$-37.1M
$-1.2M
Q2 24
$-52.4M
$-378.0K
Gross Margin
NKTR
NKTR
WHG
WHG
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Operating Margin
NKTR
NKTR
WHG
WHG
Q1 26
Q4 25
-126.9%
8.0%
Q3 25
-268.6%
8.3%
Q2 25
-324.2%
3.8%
Q1 25
-425.8%
-0.3%
Q4 24
49.2%
10.0%
Q3 24
-142.4%
-2.1%
Q2 24
-211.9%
-18.4%
Net Margin
NKTR
NKTR
WHG
WHG
Q1 26
3.1%
Q4 25
-165.4%
6.8%
Q3 25
-301.3%
15.4%
Q2 25
-372.2%
4.5%
Q1 25
-486.4%
2.1%
Q4 24
24.9%
14.5%
Q3 24
-153.6%
-5.0%
Q2 24
-222.9%
-1.7%
EPS (diluted)
NKTR
NKTR
WHG
WHG
Q1 26
$0.09
Q4 25
$-4.67
$0.21
Q3 25
$-1.87
$0.41
Q2 25
$-2.95
$0.12
Q1 25
$-0.24
$0.05
Q4 24
$-2.07
$0.45
Q3 24
$-2.66
$-0.15
Q2 24
$-3.76
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NKTR
NKTR
WHG
WHG
Cash + ST InvestmentsLiquidity on hand
$15.1M
$23.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$89.8M
$126.1M
Total Assets
$280.4M
$150.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NKTR
NKTR
WHG
WHG
Q1 26
$23.4M
Q4 25
$15.1M
$47.7M
Q3 25
$41.0M
$41.3M
Q2 25
$43.0M
$35.2M
Q1 25
$38.9M
$29.1M
Q4 24
$44.3M
$46.5M
Q3 24
$30.1M
$48.3M
Q2 24
$27.9M
$44.1M
Stockholders' Equity
NKTR
NKTR
WHG
WHG
Q1 26
$126.1M
Q4 25
$89.8M
$125.6M
Q3 25
$85.1M
$123.9M
Q2 25
$-24.2M
$122.4M
Q1 25
$13.7M
$121.4M
Q4 24
$60.7M
$120.3M
Q3 24
$48.9M
$120.4M
Q2 24
$79.7M
$120.5M
Total Assets
NKTR
NKTR
WHG
WHG
Q1 26
$150.4M
Q4 25
$280.4M
$162.3M
Q3 25
$301.3M
$154.0M
Q2 25
$207.5M
$146.3M
Q1 25
$256.2M
$135.0M
Q4 24
$303.9M
$150.0M
Q3 24
$308.0M
$151.5M
Q2 24
$343.3M
$147.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NKTR
NKTR
WHG
WHG
Operating Cash FlowLast quarter
$-65.0M
$-2.6M
Free Cash FlowOCF − Capex
$-65.0M
FCF MarginFCF / Revenue
-298.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-3.28×
TTM Free Cash FlowTrailing 4 quarters
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NKTR
NKTR
WHG
WHG
Q1 26
$-2.6M
Q4 25
$-65.0M
$18.9M
Q3 25
$-48.8M
$8.5M
Q2 25
$-45.7M
$7.3M
Q1 25
$-49.1M
$-4.9M
Q4 24
$-46.2M
$21.1M
Q3 24
$-43.9M
$529.0K
Q2 24
$-37.7M
$3.6M
Free Cash Flow
NKTR
NKTR
WHG
WHG
Q1 26
Q4 25
$-65.0M
$18.8M
Q3 25
$-48.9M
$8.5M
Q2 25
$-45.8M
Q1 25
$-49.1M
$-4.9M
Q4 24
$-46.6M
$21.0M
Q3 24
$-44.6M
$519.0K
Q2 24
$-37.9M
$3.5M
FCF Margin
NKTR
NKTR
WHG
WHG
Q1 26
Q4 25
-298.0%
69.5%
Q3 25
-414.5%
34.8%
Q2 25
-409.6%
Q1 25
-469.0%
-21.1%
Q4 24
-159.9%
45.2%
Q3 24
-184.9%
2.2%
Q2 24
-161.3%
15.6%
Capex Intensity
NKTR
NKTR
WHG
WHG
Q1 26
Q4 25
0.1%
0.3%
Q3 25
1.0%
0.3%
Q2 25
0.3%
0.0%
Q1 25
0.0%
0.0%
Q4 24
1.6%
0.2%
Q3 24
2.8%
0.0%
Q2 24
0.8%
0.1%
Cash Conversion
NKTR
NKTR
WHG
WHG
Q1 26
-3.28×
Q4 25
10.29×
Q3 25
2.29×
Q2 25
7.08×
Q1 25
-10.25×
Q4 24
-6.36×
5.69×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NKTR
NKTR

Segment breakdown not available.

WHG
WHG

Asset-based$19.3M77%
Trust fees$5.3M21%

Related Comparisons